Resmed Inc. buy Royal Bank of Canada
Start price
15.07.25
/
50%
€220.80
Target price
15.07.26
€251.96
Performance (%)
-17.19%
Price
08:00
€182.85
This prediction will end soon
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.19%. This prediction currently runs until 15.07.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 1.895% | 1.895% |
| iShares Core DAX® | -0.218% | 1.751% |
| iShares Nasdaq 100 | -2.352% | 0.218% |
| iShares Nikkei 225® | -3.105% | 2.933% |
| iShares S&P 500 | -0.497% | 1.985% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $294.00 price target on the stock.
Ratings data for RMD provided by MarketBeat